Drugs / Rabbit anti-human thymocyte immunoglobulin (ATG)
Rabbit anti-human thymocyte immunoglobulin (ATG)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07440654 Background | Mar 2026 → Sep 2029 expected | acute graft versus host disease | Nanfang Hospital, Southern Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rabbit anti-human thymocyte immunoglobulin (ATG) | “Rabbit anti-human thymocyte immunoglobulin (ATG): administered on Days -4 to -2.” NCT07440654 ↗ |
| Modality | Protein / enzyme biologic | “Rabbit anti-human thymocyte immunoglobulin (ATG)” NCT07440654 ↗ |